-
Mon18Dec2017EURORDIS headquarters, Paris, France
EURORDIS organises a ePAG face to face meeting in Paris. Paolo Federici, chair of our VASCERN ePAG group and ePAG representative for HHT will be there, together with Juergen Grunert, patient co-chair for the Medium Sized Arteries WG (vascular Ehlers Danlos), Christina Grabowski (ePAG representative for HHT) and Lise Murphy (ePAG representative for Heritable Thoracic Aortic Diseases).
-
Mon18Dec2017
-
Wed13Dec2017
-
Mon11Dec2017
-
Sat09Dec2017
-
Fri08Dec201710.30 AM (GMT+1)Videoconference call - Webex
The VASCERN Council meets every 4 months, or more depending on needs. This is the 3rd VASCERN Council meeting, following Vilnius (March) and virtual meeting last July.The Council is chaired by the Coordinator, Members are the Chairs of our Working Groups.
-
Thu07Dec2017Fri08Dec2017Rome, Italy
RD-ACTION and DG Sante organise a workshop on "How can ERNs generate, appraise and use clinical practice guidelines, to enhance the impact and deployment of consensus guidelines in national health systems?"
-
Thu07Dec2017
Publication of the call of December 7th!
JTC 2018: "Transnational research projects on hypothesis-driven use of multi-omic integrated approaches for discovery of disease causes and/or functional validation in the context of rare diseases"
More information here
-
Tue05Dec2017
-
Tue05Dec20175 PM (GMT +1)Videoconference call - Webex
-
Tue28Nov20176 PM (GMT+1)Videoconference call - Webex
Following the Paris face to face meeting during the 1st annual seminar, the VASCERN Registry WG meeting #4 will take place place virtually in November.
The VASCERN Registry WG will discuss:
- The EU common minimal dataset for Rare disease registration
- The FAIR principle, which was presented to all by Dr. Marco ROOS during our 1st Annual Seminar
-
Mon27Nov20175 PM (GMT +1)Videoconference call - Webex
The VASCERN HTAD-WG (Heritable Thoracic Aortic Diseases) monthly virtual meeting takes place every 4th Monday of every month at 5 PM (GMT +1).
The HTAD-WG will discuss:
- Patient pathway
- Clinical guidelines
- Pills of Knowledge
- Registry
- Clinical case
-
Mon20Nov20175.30 PM (GMT +1)Videoconference call - Webex
The VASCERN PPL-WG (Pediatric and Primary Lymphedema) monthly virtual meeting takes place every 3rd Monday of every month at 5.30 PM (GMT +1).
The PPL-WG will discuss:
- Patient pathways
- Clinical guidelines
- Clinical case
- Clinical guidelines
- Registry
-
Thu16Nov2017Videoconference call - Webex
Ahead of the Clinical Patient Management System (CPMS) launch, the European Commission organises a virtual meeting with the ERN Coordinators
-
Mon13Nov20177 PM (GMT+1)Videoconference call - Webex
The VASCERN VASCA-WG (Vascular Anomalies) monthly virtual meeting takes place every 2nd Monday of every month at 7 PM (GMT +1).
The VASCA-WG will discuss, among others:
- Patient pathway
- Registry
- Clinical trial
- Clinical case
-
Wed08Nov20175 PM (GMT +1)Videoconference call - Webex
The VASCERN MSA-WG monthly virtual meeting takes now place every 2nd Wednesday of every month at 5 PM (GMT +1).
The VASCERN MSA-WG will discuss:
- Patient pathways
- Patient passports
- Clinical trial
- Registry project
- Clinical case
-
Tue07Nov201710 AM (GMT +1) Videoconference call
VASCERN Patient Group (ePAG - European Patient Advocacy Group) virtual monthly meeting takes place every 1st Tuesday of every month at 10 AM (GMT +1).
-
Tue07Nov20175 PM (GMT+1)Videoconference call - Webex
VASCERN eHealth WG monthly virtual meeting takes place every 1st Tuesday of every month at 5 PM (GMT+1).
The eHealth & Training / Education WG works on:
- VASCERN-APP: A free Mobile Application for IOS and Android, which will enable patients & doctors to find and reach out easily all VASCERN Centers of expertise and Patient Organisations
- Pills of Knowledge: to develop education material available in several formats, including Videos (eLearning tools)
- Availability of conferences & videos on YouTube
-
Fri03Nov20178 AM (GMT+1) Videoconference call - Webex
The HHT-WG monthly virtual meeting takes place every 1st Friday of the month at 8 AM (GMT+1).
The HHT-WG will discuss patient pathways & complex clinical cases, among others!
-
Wed25Oct2017
-
Mon23Oct2017
-
Tue17Oct2017Sat21Oct2017
-
Mon16Oct2017
-
Sat14Oct2017Paris, France
During our 1st VASCERN Annual Seminar, which took place in Paris on October 13-14, 2017, our 5 Rare Disease Working Groups have conducted parallel face to face 3.5 hours work sessions in the morning on the 14th.
These RDWG face to face meetings have been very productive and all the 5 RDWG have made a lot of progresses in the implementation of our action plan.
-
Sat14Oct2017Paris, France
During our 1st VASCERN Annual Seminar, which took place in Paris on October 13-14, 2017, our Transversal Working Groups have conducted parallel face to face 2 hours work sessions in the afternoon on the 14th.
The eHealth & Training/Education WG, as well as the Patient Registy WG have met.
These face to face meetings have been very productive and both WGs have made a lot of progresses in the implementation of our action plan.
-
Fri13Oct2017Sat14Oct2017Paris, France
he VASCERN 1st annual seminar will take place in Paris on October 13-14th! This event will gather 80 participants, including all our Members for the first time!
Follow & tweet with us using #VASCERNdays2017
All our 31 Healthcare Providers Members will be represented by 1 or 2 representatives. 12 Patient Organisations, Members of our Patient Group (ePAG), will be represented as well.
Besides our Members, several VASCERN stakeholders (including the European Commission (ERN team, ERN IT team), ERN Board of Member States French representative, EURORDIS, FAIR Database, the European Joint Programme on Rare Diseases Research, ORPHANET, RD-Action) will be here.
On October 13th, it will be the first face-to-face gathering of all VASCERN Members since the official launch in Vilnius. This will be the opportunity to discuss:
- The structure and the functionning of the network since March, 2017;
- The state of play with regard to the implementation of our 1st year action plan (March 2017-February 2018);
- The patient involvement within VASCERN, in cooperation with EURORDIS;
- The achievements, challenges and opportunities for ERNs;
- The VASCERN Terms of Reference during the official VASCERN Board meeting.
On October 14th, the five VASCERN Rare Disease Working Groups will held parallel working sessions in the morning.
In the afternoon, the transversal WGs on eHealth-Training & Education and on Patient Registry will gather.
Programme available here
Stay tuned to get the latest news about our 1st Annual Seminar!
-
Tue10Oct2017Wed11Oct2017Brussels, Belgium
-
Mon09Oct2017
-
Fri06Oct2017
-
Tue03Oct201710:00 am (Central European Summer Time)Videoconference call
-
Tue03Oct2017
-
Thu28Sep2017Fri29Sep2017
-
Wed27Sep2017
-
Mon25Sep2017Fri29Sep2017Barcelona, Spain
Every 2 years, ISL Conference welcomes 1.000 doctors and therapy professionals from all over the world, to benefit from new research and innovate solutions to the many issues faced by health practitioners who treat people with lymphatic dysfunction.
New deadline for abstract submission : 31st March 2017More information and registration here
-
Mon25Sep2017Videoconference call
-
Mon25Sep2017
-
Sun24Sep2017Tue26Sep2017
-
Fri22Sep2017Sat23Sep2017Lyon, France
The European Society of Vascular Surgery organises its 31th annual meeting in Lyon on September, 22-23rd 2017.
All information here
-
Wed20Sep2017Antwerp, Belgium
The Aortic Aneurysm Symposium is organised by our HCP Member Prof. Bart Loeys, from the University Hospital of Antwerp (Belgium), in cooperation with Prof. Jolien Roos-Hesselink from the Erasmus Medical Center (Rotterdam, The Netherlands). Several of our HCP Members from HTAD (Heritable Thoracic Aortic Diseases) will make presentations: Prof Julie De Backer (Ghent University Hospital), Prof Yskert von Kodolitsh (University Medical Center Hamburg-Eppendorf)
More information:
-
Tue19Sep2017Milan, Italy
The Aortic Dissection Awareness Day in Milan is organised by our Member Dr Alessandro Pini. VASCERN will be presented! All information on the programme here
Info on the Aortic Dissection Awareness Day
-
Mon18Sep2017Fri22Sep2017Rome, Italy
VASCERN will be represented at this international summer school.
More info here
-
Mon18Sep2017
-
Wed13Sep2017Sun17Sep2017Geneva, Switzerland
http://eadvgeneva2017.org/
-
Tue12Sep201710:00 am (Central European Summer Time)Videoconference call
-
Sun10Sep2017Wed13Sep2017Buenos Aires, Argentina
International Symposium of Vascular Anomalies.
-
Mon28Aug201712h-13h Barcelona, Spain
In the framework of the European Society of Cardiology Congress in Barcelona, the VASCERN HTAD-WG will have its monthly WG meeting in person.
-
Sat26Aug2017Wed30Aug2017
-
Mon21Aug2017Virtual meeting - Videoconference call
Monthly meeting of the VASCERN Pediatric and Primary Lymphedema WG.
-
Wed26Jul2017Virtual meeting - Videoconference call
-
Tue25Jul2017Videoconference call
-
Mon24Jul2017Virtual meeting - Videoconference call
-
Mon17Jul2017Virtual meeting - Videoconference call
-
Thu13Jul2017Virtual meeting - Videoconference call
-
Tue11Jul2017Virtual meeting - Videoconference call
-
Thu06Jul2017Sun09Jul2017Chicago, US
-
Tue04Jul2017Videoconference call
-
Thu29Jun2017Sat01Jul2017Prague, Czech Republic
-
Thu29Jun2017Fri30Jun2017
-
Wed28Jun2017Virtual meeting - Videoconference call
VASCERN MSA-WG Monthly "virtual" meeting takes place every 4th Monday of the month at 5.30pm (GMT+1). The MSA-WG (Medium Sized Arteries - Vascular Ehlers Danlos) will discuss during these meetings all actions to be implemented by VASCERN. Once the Clinical Case Management Platform will be available, the experts will be able to discuss and share expertise for complex clinical cases to provide cross-border healthcare and conduct virtual consultations.
-
Wed28Jun2017
-
Mon26Jun2017Virtual meeting - Videoconference call
VASCERN HTAD-WG Monthly "virtual" meeting takes place every 4th Monday of the month at 5pm (GMT+1). The HTAD-WG (Heritable Thoratic Aortic Diseases) will discuss during these meetings all actions to be implemented by VASCERN. Once the Clinical Case Management Platform will be available, the experts will be able to discuss and share expertise for complex clinical cases to provide cross-border healthcare and conduct virtual consultations.
-
Mon26Jun2017Virtual meeting - Videoconference call
The next VASCERN PPL-WG Monthly "virtual" meeting will takes place on Monday 26th June, at 5pm (GMT+1). The PPL-WG (Pediatric and Primary Lymphedema) will discuss during these meetings all actions to be implemented by VASCERN. Once the Clinical Case Management Platform will be available, the experts will be able to discuss and share expertise for complex clinical cases to provide cross-border healthcare and conduct virtual consultations.
-
Tue20Jun2017Wed21Jun2017Brussels, Belgium
On June 20th & 21th, there will be a Joint meeting of the ERN Board of Member States (BoMS) and the ERN Coordinator's Group (ECG). Issues such as: call for new ERN members joining existing networks, affiliated partners, monitoring of ERNs and relationships between ERNs and Industry will be tackled.
There will be a training session on the clinical case management system.
The ECG (ERN Coordinator's Group) will meet and discuss issues such as Governance, ERN IT system, eHealth call for ERNs, research, health programme, monitoring & assessment of ERNs.
-
Wed14Jun2017Virtual meeting - Videoconference call
The VASCERN Ethics-WG first virtual meeting will take place on June 14th.
-
Mon12Jun2017Virtual meeting - Videoconference call
VASCERN VASCA-WG Monthly "virtual" meeting takes place every 2nd Monday of the month at 7pm (GMT+1). The VASCA-WG (Vascular Anomalies) will discuss during these meetings all actions to be implemented by VASCERN. Once the Clinical Case Management Platform will be available, the experts will be able to discuss and share expertise for complex clinical cases to provide cross-border healthcare and conduct virtual consultations.
-
Thu08Jun2017Sun11Jun2017Dubrovnik, Croatia
Abstract submission here until February 28th
This International event will gather world’s leading HHT experts in both basic research as well as clinical practice, including our VASCern HHT-WG Chairs and Members.
Hans Jurgen-Mager, MD, PhD, HCP Representative and Member of the VASCern HHT-WG is also Co-Chair of the Cure-HHT Organising Committee for this international meeting.
All information and registration available here
-
Thu08Jun2017Dubrovnik, Croatia
In the framework of the Cure HTT 12th International Scientific Conference held in Dubrovnik, Croatia on June 8-11th, our VASCERN HHT-WG Members will have a first VASCERN HHT-WG face-to-face meeting.
-
Tue06Jun2017Virtual meeting - Videoconference call
VASCERN ePAG (Patient Group) representatives are meeting every first Tuesday of the month at 10am (GMT+1) in order to work together, share views and be involved in all VASCERN actions.
-
Tue06Jun2017Virtual meeting - Videoconference call
VASCERN eHealth-WG monthly "virtual" meeting takes place every first Tuesday of the month at 5.30pm (GMT+1). The eHealth-WG works on all the transversal eHealth topics. The WG is especially in charge of the development of the VASCERN Mobile Application, which will facilitate cross-border healthcare and pathways throughout Europe in rare vascular diseases.
-
Thu01Jun2017Fri02Jun2017Newcastle upon Tyne, UK
VASCERN will be represented at this workshop.
"ERNs need to be able to demonstrate their impact across a broad range of fields and activities, which requires carefully-selected indicators and at the same time a monitoring system including Key Performance Indicators should be set up to follow up the activity and caseload of the ERNs."
-
Wed31May2017Paris, France
This workshop is organised by the French Ministry of Research.
-
Fri26May2017Sat27May2017
-
Mon22May2017Videoconference call
-
Fri19May2017Sat20May2017Budapest, Hungary
Save the date! All information about the meeting and the patient fellowships are available here
-
Tue16May2017Thu31Aug2017
Call identifier: ERC-2017-AdG
ERC Advanced Grant Principal Investigators are expected to be active researchers and to have a track record of significant research achievements in the last 10 years which must be presented in the application. There is little prospect of an application succeeding in the absence of such a record, which identifies investigators as exceptional leaders in terms of originality and significance of their research contributions.
More information in the ERC Work Programme 2017 (pp. 25-28 on AdG)
-
Tue16May2017
Info and registration here
-
Wed10May2017
More info here
-
Tue09May2017Videoconference call
-
Fri05May2017Videoconference call
Meeting organised by EURORDIS with the Patient Group (ePAG) on the development of the ePAG and EURORDIS support
-
Thu04May2017
More information on the call here
-
Tue02May2017Videoconference call
The eHealth WG, Chaired by Dr Alessandro Pini, Representative of our Member Centro Malattie Rare – Marfan Clinic, Milan, Italy, will have its first monthly virtual meeting on May, 2nd. The agenda includes the development of our VASCERN Mobile Application for cross-border healthcare. This Mobile Application (for IOS and Android Smartphone) will enable patients and professionals to easily find all necessary contact information about the expertise centers in rare vascular diseases.
-
Wed26Apr2017Thu27Apr2017Brussels, Belgium
-
Tue11Apr2017
Topic Identification: SC1-HCO-07-2017
Stay tuned: here
-
Tue11Apr2017
Topic identifier: SC1-HCO-03-2017
Types of action: ERA-NET-Cofund ERA-NET CofundThis call should aim at implementing a key area of the PerMed Strategic Research Agenda and be complementary with other funding programmes and activities at European and international level. Proposers are encouraged to include other joint activities including additional joint calls without EU co-funding. This work should be informed by the output of the coordination and support action envisaged in topic SC1-HCO-05-2016 - Coordinating personalised medicine research, without duplicating any of its work.
The proposed ERA-NET should demonstrate the expected impact on national and transnational programmes as well as the leverage effect on European research and competitiveness, and should plan the development of key indicators for supporting this. Participation of international partners is highly encouraged.
The Commission considers that a proposal requesting a contribution from the EU of EUR 5 million would allow this specific challenge to be addressed appropriately. Nonetheless, this does not preclude submission and selection of proposals requesting other amounts.
More information here
-
Tue11Apr2017
Topic identifier: SC1-PM-03-2017
Types of action: RIA Research and Innovation actionDeadline: 11 April 2017
The aim of this research should be to apply genomics and/or other –omics and/or other high-throughput approaches for the molecular characterisation of rare diseases in view of developing molecular diagnoses for a large number of undiagnosed rare diseases. Undiagnosed rare diseases may range from a group of unnamed disorders with common characteristics to a phenotypically well described disease or group of diseases with an unknown molecular basis. Genetic variability due to geographical distribution and/or different ethnicity should be taken into account as well as genotype-phenotype correlation whenever applicable. In addition, age, sex and gender aspects should be included where appropriate. This large-scale proposal should promote common standards and terminologies for rare disease classification and support appropriate bioinformatics tools and incentives to facilitate data sharing. Existing resources should be used for depositing data generated by this proposal. Molecular and/or functional characterisation may be part of the proposal to confirm diagnosis. The proposal should enable and foster scientific exchange between stakeholders from countries and regions with different practices and strategies of rare disease diagnostics.
The selected proposal shall contribute to the objectives of, and follow the guidelines and policies of the International Rare Diseases Research Consortium IRDiRC (www.irdirc.org).
The Commission considers that requesting a contribution from the EU of around EUR 15 million would allow this specific challenge to be addressed appropriately. Nonetheless, this does not preclude submission and selection of a proposal requesting other amounts.
More information here
-
Tue11Apr2017
Topic identifier: SC1-HCO-08-2017
Types of action: CSA Coordination and support actionAny type of activities that can help less performing countries and regions to build capacities and exploit opportunities to eventually increase their participation in EU funded collaborative projects can be supported.
The proposals will propose concrete measures for tackling structural barriers to health research and innovation, including those related to capacity, skills, policy, regulatory environment, and economic and socio-cultural factors including gender equality issues and gender dimension in research content.
More information and call documents here
-
Tue11Apr2017
Topic identifier: SC1-PM-08-2017
Types of action: RIA Research and Innovation actionDeadline: April 11th 2017
Support will be provided to clinical trials on substances where orphan designation has been given by the European Commission, where the proposed clinical trial design takes into account recommendations from protocol assistance given by the European Medicines Agency, and where a clear patient recruitment strategy is presented. Clinical trials may focus on a range of interventions with an orphan designation, from small molecule to gene or cell therapy, may include novel interventions and/or repurposing of existing and known interventions. The intervention must have been granted the EU orphan designation at the latest on the date of the full proposal call closure. A concise feasibility assessment justified by available published and preliminary preclinical or clinical results and supporting data shall also be provided. Appropriate plans to engage with patient organisations, Member States health authorities and considerations of efficacy/potential clinical benefit as well as early indication on health economics should be integrated in the application. In addition to the clinical trial, proposals may also include limited elements of late stage preclinical research and/or experimental evaluation of potential risks which must be complementary/contribute to the clinical trial(s) carried out within the proposal. The centre of gravity must clearly be the clinical trial(s). The participation of SMEs is encouraged.
More information and call documents here
-
Tue11Apr2017
Topic identifier: SC1-PM-02-2017
Types of action: RIA Research and Innovation actionDeadline: April 11th 2017
Proposals should deliver novel concepts for disease-mechanism based patient stratification to address the needs for stratified or personalised therapeutic interventions. The proposals should integrate multidimensional and longitudinal data and harness the power of -omics, including pharmacogenomics, systems biomedicine approaches, network analysis and of computational modelling. The new concepts of stratification should be validated in pre-clinical and clinical studies taking into account sex and gender differences. Applicants are encouraged to actively involve patient associations. The proposals should consider regulatory aspects of clinical practice and commercialisation opportunities. Proposals should focus on complex diseases having high prevalence and high economic impact.
The Commission considers that proposals requesting a contribution from the EU of between EUR 4 and 6 million would allow this specific challenge to be addressed appropriately. Nonetheless, this does not preclude submission and selection of proposals requesting other amounts.
More information and call documents: here
-
Tue11Apr2017
Topic identifier: SC1-PM-10-2017
Types of action: RIA Research and Innovation actionDeadline: April 11th 2017
Proposals should compare the use of currently available preventative or therapeutic (pharmacological as well as non-pharmacological) healthcare interventions in adults[1]. While there is no restriction on the diseases or interventions to be the focus of proposals, preference will be given to proposals focusing on interventions with high public health relevance and socio-economic impact, i.e. interventions addressing conditions that are particularly frequent, may lead to co-morbidities, have a high negative impact on the quality of life of the individual and/or are associated with significant costs or where savings can be achieved. A cost effectiveness analysis must be included. Given the focus on existing interventions, proposals will aim to contribute to improve interventions, take decisions about the discontinuation of interventions that are less effective or less cost-effective than others, and make recommendations on the most effective and cost-effective approaches. A comprehensive array of clinical and safety parameters, as well as health and socio-economic outcomes (e.g. quality of life, patient mortality, morbidity, costs, and performance of the health systems) for chosen populations should be assessed. Agreed core outcome sets (COS) should be used as endpoints in conditions where they already exist, in other cases efforts should be made to agree on such COS. Randomised controlled trials, pragmatic trials, observational studies, large scale databases and meta-analyses may be considered for this topic. Where relevant the study population should address gender as well as socio-economic differentials in health and/or any other factors that affect health equity.
More information and call documents here
-
Tue11Apr2017
Topic identifier: SC1-PM-20-2017
Types of action: RIA Research and Innovation actionDeadline: April 11th 2017
More information and call documents here
-
Fri07Apr2017Dublin, Ireland
Organised by Rare Diseases Ireland. Info and registration here
-
Tue04Apr2017Videoconference call
-
Fri31Mar2017
If you follow a cohort of patients with FMD, and are willing to contribute to the European FMD registry and join a network of specialists interested by the clinical and basic aspects of the disease, please contact us (FMD-saintluc@uclouvain.be).
Read the call here
-
Tue21Mar2017Wed22Mar2017Madrid, Spain
The European Commission organises a Workshop on Rare Diseases Registries in Madrid (March 21-22nd), on the dissemination of the 2008-2015 Health Programme results. This is organized in cooperation with the Centre for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III - Spanish Ministry of Economy, Industry and Competitiveness. The event will disseminate results of the EU Health Programme co-funded conducted projects and Joint Actions on Registries.
The future European platform on Rare Diseases Registration, as well as Registries through the European Reference Networks will be tackled.
Registration until March 20th here
Agenda here
-
Tue21Mar2017
Aim: increase knowledge on rare diseases and develop clinical research
Eligibility: only applicants members of approved ERNs are eligible to be co-funded.
Scope: from at least 3 countries
Description: The activities to be carried out concern the creation of 3-4 new registries on rare diseases. These registries should constitute key instruments to increase knowledge on rare diseases and develop clinical research. Collaborative efforts to establish data collection and maintain them will be considered, provided that these resources are open and accessible. Registries should be built with the support and according to the standards set up by the European Platform on rare diseases registration and provide all necessary data to the Platform (taking the relevant data protection rules into account).Call text: here
Budget: EUR 1.200.000 (indicative budgetary ceiling per grant to be awarded in 2017 is EUR 400.000, for 3 to 4 registries)
Deadline: March, 21st
All information: here
-
Mon20Mar2017Valletta, Malta
This high-level workshop is organised by the Maltese Presidency of the EU Council of the European Union at the Grand Master’s Palace , in parallel to the informal meeting of EU Ministers of Health. The Maltese Presidency has established Rare Diseases as one of its core priorities.
European Reference Networks will be represented to this meeting.
"The aim is to discuss the possibilities for structured cooperation in rare diseases research, tools, and healthcare at the EU level and ways of adapting already existing programmes by scaling them up and integrating them under the same umbrella, creating a sustainable ecosystem of knowledge generation."
-
Tue14Mar2017Teleconference call
-
Thu09Mar2017Fri10Mar2017Vilnius, Lithuania
The European Commission (DG Health) organises the 3rd European Reference Networks Conference on March, 9-10th in Vilnius, Lithuania.
The ERN Conference will focus on the presentation of the newly 24 approved European Reference Networks, and will be the official launch and start of ERNs (see here the list of approved ERNs).
There will be an ERN awarding ceremony, introduced by the EU Commissioner for Health, Vytenis Andriukaitis, who will also open the ERN Conference.
The conference on 9th will tackle topics such as:
- Coordination, management & governance of ERNs;
- ERN IT platform as core element for eHealth, telemedicine, sharing of expertise in complex clinical cases;
- EU policies and support to ENRs (research, registry platform, rare diseases policy…);
- ERN and national healthcare systems;
- The way forward with perspectives of Healthcare providers, patient representatives, ERN Coordinators, Member States.
On March 10th, the 24 new ERNs will officially start working with a kick-off meeting!
VASCERN will hold its first face-to-face Council kick-off meeting on 10th, with a part of VASCERN HCP and Patient representatives (Chairs and co-chairs of VASCERN Working Groups).
Agenda here
All information and live webstream on March, 9th here
-
Mon06Mar2017
Watch the video for the World Lymphedema Day!
-
Sun05Mar2017Wed08Mar2017Boston, Massachusetts, USA
All information and registration here
-
Tue28Feb2017
-
Tue28Feb2017University Hospital of Leuven, Belgium
The European Commission organises a ERN journalist study visit at the University Hospital of Leuven. Prof Guillaume Jondeau, VASCERN Network Coordinator and Dr Sarah Thomis, Univ. Hospital of Leuven HCP Representative, Member of the Pediatric and Primary Lymphedema WG (PPL-WG) will present VASCERN, together with a PPL Patient representative (Be-Lymph).
-
Mon27Feb2017Teleconference call
-
Thu23Feb2017
Being nearly at the half-way point of the 3rd Health Programme which runs from 2014 to 2020, the Commission would like to evaluate whether it is meeting its objectives and whether there is room for improvement.
Answer here to the EU Consultation on the 3rd European Health Programme ! It is open to any interested parties in order to gather views and opinions on:
- The objectives and priorities of the 3HP, and the extent to which these are appropriate and in line with health needs in the EU
- The way the 3HP is implemented, and the extent to which this is effective and efficient
- The overall added value and usefulness of the 3HP
More info here
-
Wed22Feb2017Thu23Feb2017
All information and registration here
-
Sat18Feb2017Antwerp, Belgium
A special event on Marfan Syndrome and Loeys-Dietz is organised by the University of Antwerp and Bindweefsel.be. More information here
-
Tue14Feb2017Teleconference call
VASCERN Vascular Anomalies (VASCA) Working Group Members first meeting as an ERN group
-
Fri10Feb2017Geneva, Switzerland
"The event is the first of its kind to be organised in Geneva and will gather international experts in the fields of public health, human rights, epidemiology, scientific research and patient advocacy to discuss why and how rare diseases should be included in the global health agenda."
All information and registration here
-
Thu09Feb2017
Call identifier: ERC-2017-CoG
Deadline: February, 9th 2017
ERC Consolidator Grants are designed to support excellent Principal Investigators at the career stage at which they may still be consolidating their own independent research team or programme. Applicant Principal Investigators must demonstrate the ground-breaking nature, ambition and feasibility of their scientific proposal. Principal Investigator shall have been awarded his or her first PhD > 7 and ≤ 12 years prior to 1 January 2017.
More information in the ERC 2017 Work Programme (pp. 23-24 on CoG)
-
Wed08Feb2017Thu09Feb2017Paris, France
-
Wed01Feb2017
The aim of the call is to enable scientists in different countries to build an effective collaboration on a common interdisciplinary research project based on complementarities and sharing of expertise, with a clear translational research approach. Projects shall involve a group of rare diseases or a single rare disease following the European definition i.e. a disease affecting not more than five in 10.000 persons in the European Community, EC associated states and Canada.
The specific objective of this call is to promote research projects focusing on the pre-clinical development of therapeutic approaches in suitable existing animal or cell models.
Date of publication: December 5th
Deadline for proposal pre-registration: February 1, 2017
Deadline for proposal submission: June 2nd, 2017
More information here
Call document: here
Call forms: here
Guidelines: here
-
Tue31Jan2017
The European Commission (DG Health) has launched a new call for proposals for a pilot project in the area of Rare Diseases. This will be founded by the European 3rd Health Programme.
PP-2-1-2016 - Pilot project — Establishing a Registry of Rare Congenital Malformations (as part of the Rare Diseases Registry), drawing on the structure, organization and experience of the Registry of Congenital Malformations
- The key objective of this pilot project is to set up a registry of rare congenital malformations as a part of rare diseases national registers. The project should be implemented at a national level.
- The secondary aim of the project is to provide an example of how to extend an existing birth defects registration and surveillance system to a rare diseases registration system.
- The birth defects registration system has already been set up in several MSs as part of the EUROCAT surveillance network. The pilot project provides a model for exploring whether a birth defects registry can be extended to form a rare diseases registry.
- The pilot project should contribute to the development of an EU Platform on Rare Diseases Registration to provide a common access point to data collections on rare diseases across Europe and to be compatible with platform tools.
Opening: October 27th 2016
Deadline: January 31st 2017
Call document: here
More information and link for submission here -
Wed25Jan2017Sat28Jan2017Turin, Italy
Prof Guillaume Jondeau will present VASCERN at the 20th Turin Meeting on Rare Diseases (ERN Roundtable). The European Commission as well as 5 other ERNs will be there and make presentations!
-
Sun15Jan2017
The objective of the consultation is to collect information from a wide audience on different aspects of Horizon 2020 implementation. The results of this consultation will feed into the report on the interim evaluation of Horizon 2020, will help the European Commission to improve the implementation of Horizon 2020 and will set the scene for the future discussions on the next EU research and innovation funding post-2020.
Answer to the consultation here
Deadline: January 15th 2017
-
Tue10Jan2017
All information on the calls for Innovative Training Networks available here
Deadline: January 10th 2017